TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Pulmonary vascular remodeling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Red Blood Cell Signal from Xenon MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Complete Response Rate (CCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elbow Dynamometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Motor strength in medical research council grade (MRC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Electrodiagnosis (Nerve Conduction Study and Electromyography)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: User Experience / User Acceptance Indicators
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Completion of Home Transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-Reported Data
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Volume of quantitative blood loss at delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from baseline in the 12-item Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog12)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in stereoacuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects with AKI within 7 days following on-pump cardiac surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Implantation Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cycloplegic auto-refraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the modified Rodnan Skin Score (mRSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of Participants With Serious Adverse Events (SAE's)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Discontinued Treatment due to Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: high sensitivity C-Reactive Protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chemokine (C-X-C motif) ligand 9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 25-hydroxy vitamin D
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of serological response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Area under the plasma concentration curve from time zero to the last quantifiable concentration (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative milligram morphine equivalents (MME)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Movement disorders Society Unified Parkinson's Disease Rating Scale Part IV total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corsi Blocks product score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: rate of change in iron accumulation in the substantia nigra pars compacta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Probe performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disappearance of cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of treatment responders at post-treatment on the Clinical Global Impression Improvement Scale (CGI-I)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of treatment responders at follow-up on the Clinical Global Impression Improvement Scale (CGI-I)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient changes in overall symptom severity on the Clinical Global Impression Severity Scale (CGI-S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Troponin I
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction of infusion duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Documentation of Patient Priorities Care discussion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Safety as measured by dose limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility as measured by the rate of participants receiving planned treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Total GA Lesion Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chest auscultation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants with a Hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Patient Session Engagement
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Brief Psychiatric Rating Scale Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Urine Analysis results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Cervical swab results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiotracer distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean oocyte score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: General Practitioner attendance
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Fatigability from Wechsler Adult Intelligence Scale (WAIS)-IV Coding Test
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Fatigability on e-prime vigilance task in the fMRI scanner
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Multidimensional Fatigue Inventory-20
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Geometric mean titers (GMT) of neutralizing antibodies (nAb) against Omicron subvariant (BA.5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quality of Socialization Questionnaire-Revised (QSQ-R)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Number of images
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: PSA progesterone-free survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Radiographic PFS (rPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Immediate Postoperative Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's self-rescue ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ORS Use (cases in last 4 weeks)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Concentration of ALT and AST enzymes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in scores of Canadian Occupational Performance Measure
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: target-vessel failure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Presence of C. butyricum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Presence of C. neonatale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Culture of C. butyricum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Culture of C. neonatale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in kidney oxygenation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: adherence to the exercise intervention
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: acceptability of platforms used
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Self-reported Cognitive Functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in absolute neutrophil count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Chemical hazards occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Measurement of the length of the philtral column
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angle of the columella
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance from the midpoint of the columella to the lateral alae
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease reversal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication reduction
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Compliance with diet tracking prescription
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Persistence with diet tracking prescription
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Acceptability of tracking prescription
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of participants with sodium level >135mEq/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximal diameter of main pancreatic duct
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Alive-and-ventilator free days
Endpoint domain: Mortality/survival
Primary endpoint: Number of invasive diagnostic procedures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Overall Length of Stay (LoS)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Percentage Change in Forced Expiratory Volume in the First Second (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage Change in Peak Expiratory Flow (PEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Subject compliance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: The State Anxiety Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Personal Well-Being Index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Area under the concentration-time curve from time 0 extrapolated to infinity (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variation in the size of the latent cellular reservoir of HIV-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: accrual
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage enrolled of patients undergoing elective VHRs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Perceived psychological and behavioural barriers to adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in RSA Migrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Index of Erectile Function
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: decrease of decompensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in UUI episodes by > 50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average number of hot flashes per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gut derived metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adherence to guidelines for IBS diagnosis
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Caregiver IADL Decline
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Patient IADL Decline
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Caregiver BADL Decline
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient BADL Decline
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in overactive bladder symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of implants location
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Screw positioning accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Correction angles accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Uncorrected Near Visual Acuity at 14cm Change From Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Boezaart Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotional Appetite Questionnaire (EAQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ruminative Thought Style Questionnaire (RTSQ)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cognitive Triad Inventory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of solution induced corneal staining (SICS)
Endpoint domain: Adverse events/effects
Primary endpoint: MRC sum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: FSS-ICU
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: JH-highest mobility scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: US (muscle thickness)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Fitbit charge 5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of device related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Gixam's sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gixam's specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mindful Breastfeeding Scale (MIND-BFS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CGRP level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: DNA test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: I-GERQ-R questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean number of urgency episodes per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor-related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor-related pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of 2-year lymph node metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: proportion of patients still receiving a JAK-inhibitor
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of acute attacks per year
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: The number of acute exacerbations per year
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: The number of rehospitalizations within a year
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Absorption of PA and carotenoids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Uncertainty Intolerance Scale - II
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Metacognitive Belief Questionnaire - MCQ-30
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Short Form Health Survey - SF-36
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: MCI tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Middle molecular weight toxins clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leg Strength Assessed Through a 30 Second Chair Rise Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total analgesic requirements
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Framingham risk score (FRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Bone width in millimeters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AMD evolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of qualitative [18F]FES PET/CT evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in GI tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of patient compliance with consumption of the prescribed volume of study product
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in product acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effort perception
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: one-year proportion of children with new cavities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: mean number of new cavities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: one-year proportion of children with inactive cavities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: mean number of inactive cavities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Gixam's sensitivity
Endpoint domain: Physiological/clinical
Primary endpoint: Gixam's specificity
Endpoint domain: Physiological/clinical
Primary endpoint: Rate of Isthmocele
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ultrasonographic Measurements of Isthmocele
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: eGFR as determined by serum creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Time-to treatment discontinuation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of new bone formed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of adult CO-GHD patients receiving regular medical follow-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Intensity of neuropathic low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hypertension in pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Preterm labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NICU infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neonatal outcomes
Primary endpoint: Hand Held Dynamometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pinch gauge meter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful application of online adaptive treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rational Drug Use Scale
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: BNP decline rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: discomfort scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: increase in oral feeding volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of dominant follicles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Attitudes toward lesbians and gay men
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Genderism and Transphobia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Attitudes Toward sex workers with HIV and STDs
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Observed concentration before dosing (Cthrough) at steady state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and severity of treatment-emergent Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Serious Adverse Drug Reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Adverse Reactions Categorized as Inhibitor Development, Shock, or Anaphylaxis
Endpoint domain: Adverse events/effects
Primary endpoint: Initiation of sexual intercourse
Endpoint domain: Life impact
Endpoint subdomain: Reproductive system and breast outcomes